A asymmetric hydrogenation

Yamaguchi H, Hirano T, Kiminami H, Taura D, Harada A. Asymmetric hydrogenation with antibody-achiral rhodium complex. Org. Biomol. Chem. 2006 4 3571-3573. 

Site A asymmetric hydrogenation site according to the Template model resulting (./ )-(-)-MeLa. 

Sablong, R. Osborn, J. A. Asymmetric hydrogenation of imines catalysed by carboxylato(diphosphine)iridium(III) complexes. Tetrahedron Asymmetry 1996, Z 3059-3062. 

Gruber, S. Pfaltz, A. Asymmetric hydrogenation with iridium C, N and N, P ligand complexes Characterization of dihydride intermediates with a coordinated alkene. Angew. Chem. hit. Ed. 2014,53,1896-1900. 

Tetrahedron, 1993, 49, 6605 (d) Selke, R., Ohff, M. and Riepe, A., Asymmetric hydrogenation - influence of the structure of carbohydrate derived catalysts on the relative enantioselectivity Qn/Me regarding acid and ester substrates and its inversion. Selectivity increase in water by amphiphiles. Tetrahedron, 1996, 52, 15079 (e) Selke, R., Holz, J., Riepe, A. and Bdmer, A., Impressive enhancement of theenantioselectivity for a hydroxy containing rhodium (I) bisphosphine catalyst in aqueous solution by micelle forming amphiphiles, Chem. Ear. 1998,4, 769. 

Selbe, R., Ohff, M. and Riepe, A., Asymmetric hydrogenation - influence of the structure of carbohydrate derived catalysts on the relative enantioselectivity of Qh/Mc regarding acid and ester substrates and its inversion selectivity increase in water by amphiphiles. Tetrahedron, 1996,52, 15079. 

Woodmansee DH, Pfaltz A. Asymmetric hydrogenation of alkenes lacking coordinating groups. Chem. Commun. 2011 47 7912-7916. 

Bell S, Wiistenberg B, Kaiser S, Menges F, Netscher T, Pfaltz A. Asymmetric hydrogenation of nfunuctionalized, purely alkyl-substituted olefins. Science 2006 311(5761) 642-644. 

Asymmetric hydrogenation has been achieved with dissolved Wilkinson type catalysts (A. J. Birch, 1976 D. Valentine, Jr., 1978 H.B. Kagan, 1978). The (R)- and (S)-[l,l -binaph-thalene]-2,2 -diylblsCdiphenylphosphine] (= binap ) complexes of ruthenium (A. Miyashita, 1980) and rhodium (A. Miyashita, 1984 R. Noyori, 1987) have been prepared as pure atrop-isomers and used for the stereoselective Noyori hydrogenation of a-(acylamino) acrylic acids and, more significantly, -keto carboxylic esters. In the latter reaction enantiomeric excesses of more than 99% are often achieved (see also M. Nakatsuka, 1990, p. 5586). 

Catalytic asymmetric hydrogenation was one of the first enantioselective synthetic methods used industrially (82). 2,2 -Bis(diarylphosphino)-l,l -binaphthyl (BINAP) is a chiral ligand which possesses a Cg plane of symmetry (Fig. 9). Steric interactions prevent interconversion of the (R)- and (3)-BINAP. Coordination of BINAP with a transition metal such as mthenium or rhodium produces a chiral hydrogenation catalyst capable of inducing a high degree of enantiofacial selectivity (83). Naproxen (41) is produced in 97% ee by... 

Enzymatic hydrolysis of A/-acylamino acids by amino acylase and amino acid esters by Hpase or carboxy esterase (70) is one kind of kinetic resolution. Kinetic resolution is found in chemical synthesis such as by epoxidation of racemic allyl alcohol and asymmetric hydrogenation (71). New routes for amino acid manufacturing are anticipated. 

Asymmetric synthesis is a method for direct synthesis of optically active amino acids and finding efficient catalysts is a great target for researchers. Many exceUent reviews have been pubHshed (72). Asymmetric syntheses are classified as either enantioselective or diastereoselective reactions. Asymmetric hydrogenation has been appHed for practical manufacturing of l-DOPA and t-phenylalanine, but conventional methods have not been exceeded because of the short life of catalysts. An example of an enantio selective reaction, asymmetric hydrogenation of a-acetamidoacryHc acid derivatives, eg, Z-2-acetamidocinnamic acid [55065-02-6] (6), is shown below and in Table 4 (73). 

The most recent, and probably most elegant, process for the asymmetric synthesis of (+)-estrone appHes a tandem Claisen rearrangement and intramolecular ene-reaction (Eig. 23). StereochemicaHy pure (185) is synthesized from (2R)-l,2-0-isopropyhdene-3-butanone in an overall yield of 86% in four chemical steps. Heating a toluene solution of (185), enol ether (187), and 2,6-dimethylphenol to 180°C in a sealed tube for 60 h produces (190) in 76% yield after purification. Ozonolysis of (190) followed by base-catalyzed epimerization of the C8a-hydrogen to a C8P-hydrogen (again similar to conversion of (175) to (176)) produces (184) in 46% yield from (190). Aldehyde (184) was converted to 9,11-dehydroestrone methyl ether (177) as discussed above. The overall yield of 9,11-dehydroestrone methyl ether (177) was 17% in five steps from 6-methoxy-l-tetralone (186) and (185) (201). 

Monsanto s commercial route to the Parkinson s drug, L-DOPA (3,4-dihydroxyphenylalanine), utilizes an Erlenmeyer azlactone prepared from vanillin. The pioneering research in catalytic asymmetric hydrogenation by William Knowles as exemplified by his reduction of 24 to 25 in 95% ee with the DiPAMP diphosphine ligand was recognized with a Nobel Prize in Chemistry in 2001. ... 

Both reactions were carried out under two-phase conditions with the help of an additional organic solvent (such as iPrOH). The catalyst could be reused with the same activity and enantioselectivity after decantation of the hydrogenation products. A more recent example, again by de Souza and Dupont, has been reported. They made a detailed study of the asymmetric hydrogenation of a-acetamidocin-namic acid and the kinetic resolution of methyl ( )-3-hydroxy-2-methylenebu-tanoate with chiral Rh(I) and Ru(II) complexes in [BMIM][BF4] and [BMIM][PFg] [55]. The authors described the remarkable effects of the molecular hydrogen concentration in the ionic catalyst layer on the conversion and enantioselectivity of these reactions. The solubility of hydrogen in [BMIM][BF4] was found to be almost four times higher than in [BMIM][PFg]. 

The influence of the concentration of hydrogen in [BMIM][PFg] and [BMIM][BF4] on the asymmetric hydrogenation of a-acetamidocinnamic acid catalyzed by rhodium complexes bearing a chiral ligand has been investigated. FFydrogen was found to be four times more soluble in the [BFJ -based salt than in the [PFg] -based one. 

The first application involving a catalytic reaction in an ionic liquid and a subsequent extraction step with SCCO2 was reported by Jessop et al. in 2001 [9]. These authors described two different asymmetric hydrogenation reactions using [Ru(OAc)2(tolBINAP)] as catalyst dissolved in the ionic liquid [BMIM][PFg]. In the asymmetric hydrogenation of tiglic acid (Scheme 5.4-1), the reaction was carried out in a [BMIM][PF6]/water biphasic mixture with excellent yield and selectivity. When the reaction was complete, the product was isolated by SCCO2 extraction without contamination either by catalyst or by ionic liquid. 

In a similar manner, the asymmetric hydrogenation of isobutylatropic acid to afford the anti-inflammatory dmg ibuprofen has been carried out (Scheme 5.4-2). Here, the reaction was carried out in a [BMIM][PFg]/MeOH mixture, again followed by product extraction with SCCO2 (see Section 5.2.4.1 for more details on these hydrogenation reactions). 

An early success story in the field of catalytic asymmetric synthesis is the Monsanto Process for the commercial synthesis of l-DOPA (4) (see Scheme 1), a rare amino acid that is effective in the treatment of Parkinson s disease.57 The Monsanto Process, the first commercialized catalytic asymmetric synthesis employing a chiral transition metal complex, was introduced by W. S. Knowles and coworkers and has been in operation since 1974. This large-scale process for the synthesis of l-DOPA (4) is based on catalytic asymmetric hydrogenation, and its development can be... 

Styrene, a-ethyl-asymmetric hydroformylation catalysts, platinum complexes, 6, 266 asymmetric hydrogenation catalysts, rhodium complexes, 6, 250 Styrene, a-methyl-asymmetric carbonylation catalysis by palladium complexes, 6, 293 carbonylation... 

Asymmetric syntheses of warfarin <96TL8321> and the axially chiral bicoumarin, isokotanin A <96TL3015> have been reported. The former is based on a Rh-catalysed asymmetric hydrogenation of a 3-(a,P-unsaturated ketone) substituted coumarin, whilst the key steps of the latter are an asymmetric Ullmann coupling and a selective demethylation. The stereochemistry of the fused dihydrocoumarin resulting from Li/NHs reduction of... 

Although the asymmetric hydrogenation of itaconic acid derivatives is a potential synthetic approach to many useful product [105], lower enantioselectivities are often reported. In contrast with other catalysts, f-Bu-BisP, Ad-BisP, t-Bu-MiniPHOS, BIPNOR 27, and Brown s ligand 25 gave high to almost perfect ees in the hydrogenation of these substrates (Scheme 23) [101]. 

The rhodium complex of the (R,R)-counter-enantiomer of (S,S)-BisP achieved a high level of ee (97%) in the asymmetric hydrogenation of 3-methoxy-substituted substrate (S)-122 (Scheme 25), which constitutes a precursor to the acetylcholinesterase inhibitor SDZ-ENA-713 (123). 

---